COMMUNIQUÉS West-GlobeNewswire

Inventiva annonce la mise à disposition d'un prospectus dans le cadre de son financement par l’émission d’actions ordinaires et de bons de souscription d’action préfinancés

14/10/2024 - 19:45

Daix (France), Long Island City (New York, États-Unis), le 14 octobre 2024 – Inventiva (Euronext Paris et Nasdaq: IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement [...]

Inventiva announces the availability of a prospectus in connection with its financing through the issuance of ordinary shares and pre-funded warrants

14/10/2024 - 19:45

Daix (France), Long Island City (New York, United States), October 14, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the [...]

The Association of American Physicians and Surgeons (AAPS) Sues to Block Expansion of the Federal Police State

14/10/2024 - 19:50

TUCSON, Ariz., Oct. 14, 2024 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons (“AAPS”) served a lawsuit on Oct 11, seeking to block the upcoming requirement that tens of millions Americans provide [...]

Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial

14/10/2024 - 22:05

The study found improvements in reading speed, vision-related quality of life, and suggested potential benefits of an interventional approach for patients with dry eye disease MENLO PARK, Calif., Oct. 14, 2024 (GLOBE [...]

Spectral AI, Inc. Announces Return of Founder Dr. J. Michael DiMaio as Chairman of the Board of Directors

14/10/2024 - 22:05

DALLAS, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

14/10/2024 - 22:15

Southlake, TX, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology [...]

The Joint Corp. Appoints Sanjiv Razdan President and Chief Executive Officer

14/10/2024 - 22:15

-Seasoned Franchise Executive to also Join the Company’s Board of Directors - SCOTTSDALE, Ariz., Oct. 14, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) (“The Joint or “the Company”), the nation’s largest [...]

Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 septembre 2024

14/10/2024 - 22:30

Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 septembre 2024 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE [...]

Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024

14/10/2024 - 22:30

Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : [...]

Travere Therapeutics to Present Abstracts at American Society of Nephrology (ASN) Kidney Week 2024

14/10/2024 - 22:30

Data presentations highlight the results for FILSPARI ® (sparsentan), the only approved kidney-targeted medicine for IgA nephropathy, when used as a first-line treatment, and in combination with other therapies Late- [...]

Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece

14/10/2024 - 23:00

-- Reimbursement Determination for the PoNS Mouthpiece (HCPCS code A4594) set at $2,963.30 on Lump Sum Payment to be challenged by Helius -- -- National Reimbursement Payment Determination from CMS for its PoNS [...]

Quest PharmaTech Announces Results from AGM

11/10/2024 - 23:00

EDMONTON, Alberta, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results of its October 8, 2024 annual general meeting of shareholders. The Company [...]

MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN

11/10/2024 - 23:15

DALLAS, TX, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“ MangoRx ” or the “ Company ”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products [...]

Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society

12/10/2024 - 12:30

-Subject 1 and Subject 2 experienced durable, clinically meaningful improvements in swallowing at 9-months and 6-months post-BB-301 treatment, respectively, with Subject 2 achieving a Sydney Swallow Questionnaire Score [...]

Sandoz US launches generic paclitaxel in single-dose vial, further expanding US oncology portfolio

11/10/2024 - 07:00

MEDIA RELEASE First FDA-approved abbreviated new drug application (ANDA) to reference medicine Single-dose 100 mg vial for intravenous use, approved for metastatic breast cancer Launch expected to be near-term growth [...]

NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting

11/10/2024 - 07:00

NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting Aarhus, Denmark, 11 October 2024 – NMD Pharma A/S, a clinical-stage biotech company [...]

Communiqué de presse : Sanofi en discussions pour céder une participation majoritaire dans Opella

11/10/2024 - 08:30

Sanofi en discussions pour céder une participation majoritaire dans Opella Paris, 11 octobre 2024 . Sanofi a annoncé aujourd'hui avoir entamé des négociations avec CD&R pour la cession potentielle d’une [...]

Press Release: Sanofi in discussions to sell a controlling stake in Opella

11/10/2024 - 08:30

Sanofi in discussions to sell a controlling stake in Opella Paris, October 11, 2024 . Sanofi today announces that the company has entered into negotiations with CD&R for the potential sale of a 50% controlling stake [...]

Communiqué de presse : Sanofi en discussions pour céder une participation majoritaire dans Opella

11/10/2024 - 08:50

Sanofi en discussions pour céder une participation majoritaire dans Opella Paris, 11 octobre 2024 . Sanofi a annoncé aujourd'hui avoir entamé des négociations avec CD&R pour la cession potentielle d’une [...]